Clinical trial
Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease Study
NCT00053599
Study timeline
Study start (unknown)2002-12-01Date precision: month
Registry last updated2009-07-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Alzheimer Diseaseunresolved
Interventions
SimvastatinDRUG · verified · RxNorm: simvastatin
Sponsors & collaborators
National Institute on Aging (NIA)lead sponsor
Alzheimer's Disease Cooperative Study (ADCS)collaborator
Mapped research locations
New YorkNew York, United States3BostonMassachusetts, United States2ChicagoIllinois, United States2Los AngelesCalifornia, United States2St LouisMissouri, United States2Washington D.C.District of Columbia, United States2HoustonTexas, United States1PhiladelphiaPennsylvania, United States1DallasTexas, United States1AtlantaGeorgia, United States1SeattleWashington, United States1ClevelandOhio, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00053599 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.